You are here:Home-Chemical Inhibitors & Agonists-Tyrosine Kinase-Anaplastic Lymphoma Kinase (ALK)-TQ-B3139
TQ-B3139

Chemical Structure : TQ-B3139

CAS No.: 1621519-26-3

TQ-B3139 (Envonalkib, CT-711)

Catalog No.: PC-49613Not For Human Use, Lab Use Only.

TQ-B3139 (Envonalkib, CT-711) is a potent inhibitor of ALK and c-Met kinases with IC50 of 14.3 and 12.5 nM in cell-free assays, respectively.

Packing Price Stock Quantity
2 mg $198 In stock
5 mg $328 In stock
10 mg $528 In stock
25 mg $898 In stock
50 mg Get quote
100 mg Get quote

Bulk size, bulk discount!

E-mail: sales@probechem.com

Tech Support: tech@probechem.com

Purity & Documentation Purity: >98% (HPLC) Select Batch:

Biological Activity

TQ-B3139 (Envonalkib, CT-711) is a potent inhibitor of ALK and c-Met kinases with IC50 of 14.3 and 12.5 nM in cell-free assays, respectively.
TQ-B3139 (CT-711) inhibits ALK signaling pathway and induces G1 arrest and apoptosis.
TQ-B3139 (CT-711) is an ALK inhibitor with improved ALK inhibitory activity compared with crizotinib.
TQ-B3139 (CT-711) is preferentially efficacious against cells expressing EML4-ALK (NCI-H3122, NCI-H2228), NPM1-ALK (SU-DHL-1) and ALK activating F1174L point mutation (SK-N-SH) with IC50 of 15-500 nM, but not ALK wild-type cells (NCI-H460, HCC827).
TQ-B3139 (CT-711) inhibits c-Met and overcomes resistance conferred by c-Met activition.
TQ-B3139 (CT-711) at a dose of 25 mg/kg inhibits the growth of ALK-driven tumors in vivo, exhibits significantly superiority to crizotinib against 32D harboring EML4-ALK L1196M and EML4-ALK C1156Y mutations.
Envonalkib is a potent, selective, and orally active inhibitor of ALK with IC50 of 1.96 nM, 35.1 nM, and 61.3 nM for WT and mutated L1196M and G1269S-ALK, respectively.
Envonalkib (12.5-25 mg/kg; p.o. once daily for 14 days) inhibits the growth of human non-small cell lung cancer NCI-H2228 nude mice xenografts.

Physicochemical Properties

M.Wt 506.40
Formula C24H26Cl2FN5O2
Appearance Solid
CAS No.
Storage
Solide Powder
-20°C 12 Months; 4°C 6 Months
In Solvent
-80°C 6 Months; -20°C 6 Months
Shipping
Solubility

10 mM in DMSO

Chemical Name/SMILES

5-((R)-1-(2,6-dichloro-3-fluorophenyl)ethoxy)-4'-methoxy-6'-((S)-2-methylpiperazin-1-yl)-[3,3'-bipyridin]-6-amine

References

1. Yuxiang Ma, et al. Eur J Cancer. 2022 Sep;173:238-249.

Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright

Contact Us sales@probechem.com

Bulk Inquiry

* Indicates a Required FieldYour information is safe with us.

  • *Product name:
  • *Applicant name:
  • *Email address:
  • *Organization name:
  • *Requested quantity:
  • *Country:
  • *Additional Information:

Get Quote

* Indicates a Required FieldYour information is safe with us.

  • *Product name:
  • *Applicant name:
  • *Email address:
  • *Organization name:
  • *Requested quantity:
  • *Country:
  • Additional Information: